Chronic Lymphocytic Leukemia (CLL) · Fase 2 · NCT07508995
BGB-16673, BGB-11417
M.D. Anderson Cancer Center · Abrir el resumen
Leucemia mieloide aguda · Fase 2 · NCT07437950
Biospecimen Collection, Bone Marrow Aspiration, Decitabine and Cedazuridine, Venetoclax
National Cancer Institute (NCI) · Abrir el resumen
Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma · Fase 2 · NCT07583810
Biopsy Procedure, Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography
City of Hope Medical Center · Abrir el resumen
Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · Fase 2 · NCT07194980
Nemtabrutinib, Lisocabtagene Maraleucel
Fred Hutchinson Cancer Center · Abrir el resumen
Leucemia mieloide aguda · Fase 2 · NCT05554406
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration, Cytarabine
National Cancer Institute (NCI) · Abrir el resumen
Core Binding Factor Acute Myeloid Leukemia · Fase 2 · NCT06917911
Biospecimen Collection, Bone Marrow Aspiration, Cytarabine, Daunorubicin Hydrochloride
National Cancer Institute (NCI) · Abrir el resumen
Linfoma de células B en recaída o refractario · Fase 1/2 · NCT03223610 · Artículos
Venetoclax, ibrutinib, prednisone, obinutuzumab y Revlimid (ViPOR) en linfoma de células B en recaída o refractario
National Cancer Institute (NCI) · Abrir el resumen
Leucemia mieloide aguda · Fase 2 · NCT05554393
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration, Cytarabine
National Cancer Institute (NCI) · Abrir el resumen
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative · Fase 2 · NCT03739814 · Artículos
Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Bone Marrow Biopsy
National Cancer Institute (NCI) · Abrir el resumen
Grade 3b Follicular Lymphoma · Fase 2 · NCT05890352
Biospecimen Collection, Computed Tomography, Lenalidomide, Magnetic Resonance Imaging
SWOG Cancer Research Network · Abrir el resumen
Recurrent Multiple Myeloma · Fase 2 · NCT06948084
Biospecimen Collection, Bone Marrow Biopsy, Carfilzomib, Computed Tomography
National Cancer Institute (NCI) · Abrir el resumen
Leucemia mieloide aguda · Fase 2 · NCT06317649
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy
National Cancer Institute (NCI) · Abrir el resumen
Accelerated Phase Myeloproliferative Neoplasm · Fase 2 · NCT06661915
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Decitabine and Cedazuridine
National Cancer Institute (NCI) · Abrir el resumen
B Acute Lymphoblastic Leukemia · Fase 2 · NCT06124157
Biospecimen Collection, Blinatumomab, Bone Marrow Biopsy, Calaspargase Pegol
National Cancer Institute (NCI) · Abrir el resumen
Leucemia mieloide aguda · Fase 2 · NCT06672146
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Decitabine and Cedazuridine
National Cancer Institute (NCI) · Abrir el resumen
Hematologic Malignancies · Fase 2 · NCT04728893
Nemtabrutinib
Merck Sharp & Dohme LLC · Abrir el resumen
Leucemia mieloide aguda · Fase 2 · NCT07304011
Azacitidine, Olutasidenib
University of California, Davis · Abrir el resumen
T-cell Lymphoma · Fase 2 · NCT07356245
Ruxolitinib, Positron emission tomography-computed tomography, Bone Marrow Biopsy, Biopsy Procedure
Ohio State University Comprehensive Cancer Center · Abrir el resumen
Mielofibrosis · Fase 2 · NCT07447817
Pacritinib, Selinexor
John Mascarenhas · Abrir el resumen
Acute Leukemia of Ambiguous Lineage · Fase 2 · NCT06317662
Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration
National Cancer Institute (NCI) · Abrir el resumen
Non-Hodgkin's Lymphoma · Fase 2 · NCT04002947 · Artículos
DA-EPOCH, Rituximab, CHOP, Acalabrutinib
National Cancer Institute (NCI) · Abrir el resumen
Chronic Lymphocytic Leukemia · Fase 2 · NCT03516617
Acalabrutinib, Laboratory Biomarker Analysis, Obinutuzumab, Patient Observation
Mayo Clinic · Abrir el resumen
Linfoma no Hodgkin de células B · Fase 1/2 · NCT05442515 · Artículos
Células T con receptor de antígeno quimérico (CAR) bicistrónico CD19/CD22 en niños y adultos jóvenes con neoplasias de células B recurrentes o refractarias
National Cancer Institute (NCI) · Abrir el resumen
Leucemia linfoblástica aguda · Fase 2 · NCT07328503
CD22 CAR-transduced T cells, Cyclophosphamide, Fludarabine
National Cancer Institute (NCI) · Abrir el resumen